DelveInsight's Companion Diagnostics Market Insights report provides the current and forecast market analysis, individual ...

Zydus Lifesciences Limited, an innovation-led global life sciences company, today announced its new offering companion ...

With an eye toward better matching its targeted therapeutics to the patients who will benefit most, Incyte has turned to Agilent Technologies to develop companion diagnostics for its drugs. The duo ...

Recently, the U.S. Food and Drug Administration, or FDA, issued a draft guidance 1 (the guidance) outlining considerations for the development and labeling of in vitro companion diagnostics to support ...

Last summer, the Food & Drug Administration published its final guidance on the development and approval path for companion diagnostics. These in vitro tests and devices put personalized medicine into ...

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Companion Diagnostic Collaboration and Licensing Deals 2010-2025" has been added to ResearchAndMarkets.com's offering. This report contains a ...

The Companion Diagnostics Market has emerged as a critical pillar of modern precision medicine, enabling healthcare providers ...

Never has there been more information to enable a patient’s fight against cancer, but how does one select the right treatment? This is how companion diagnostics fit with precision medicine. Advances ...

Dr. El-Gabry succeeds Mark Kockx, MD, PhD, CellCarta co-founder and long-serving Chief Medical Officer, who is stepping down from his executive responsibilities to focus on his health. Mark's ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Almost half of drug research companies pay between $1 million and $5 million to develop targeted therapeutic technologies that increase the effectiveness ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. At Illumina’s Genomics Forum conference this fall, former ...